1. Home
  2. RANI vs GOAI Comparison

RANI vs GOAI Comparison

Compare RANI & GOAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

HOLD

Current Price

$0.86

Market Cap

106.9M

Sector

Health Care

ML Signal

HOLD

Logo Eva Live Inc. Common Stock

GOAI

Eva Live Inc. Common Stock

N/A

Current Price

$8.00

Market Cap

89.9M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
RANI
GOAI
Founded
2012
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
106.9M
89.9M
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
RANI
GOAI
Price
$0.86
$8.00
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$7.50
N/A
AVG Volume (30 Days)
1.0M
92.1K
Earning Date
05-07-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
57.14
966.67
EPS
N/A
N/A
Revenue
$1,633,000.00
$17,037,328.00
Revenue This Year
$274.77
N/A
Revenue Next Year
$79.44
N/A
P/E Ratio
N/A
N/A
Revenue Growth
58.85
82.59
52 Week Low
$0.44
$1.42
52 Week High
$3.87
$6.67

Technical Indicators

Market Signals
Indicator
RANI
GOAI
Relative Strength Index (RSI) 58.60 53.51
Support Level $0.86 $1.69
Resistance Level $0.95 $2.68
Average True Range (ATR) 0.06 0.17
MACD 0.01 0.05
Stochastic Oscillator 65.07 92.31

Price Performance

Historical Comparison
RANI
GOAI

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

About GOAI Eva Live Inc. Common Stock

Eva Live Inc is a United States-based technology company that has developed an automated and intelligent advertiser campaign management platform, Eva Platform, which enables advertisers ('customers, clients') to buy advertising space on several digital channels to reach their desired audience. The company also works with Businesses that utilize its in-house digital marketing capabilities, including advice, creative services, account management, production of advertising materials, media planning, and buying.

Share on Social Networks: